Computational Studies toward the Identification of CB2R-M1R Dual Modulators.

Area of Science:

• Neuroscience
• Pharmacology
• Computational Chemistry

Background:

• Neurodegenerative disorders are complex, limiting monotherapy effectiveness.
• Multitarget-directed ligand strategies offer a promising therapeutic avenue.
• Cannabinoid receptor type 2 (CB2R) and muscarinic acetylcholine receptor subtype 1 (M1R) are implicated in neurological diseases.

Purpose of the Study:

• To identify dual modulators targeting both CB2R and M1R.
• To explore a computational approach for discovering multitarget ligands.
• To provide starting points for developing new treatments for neurodegenerative conditions.

Main Methods:

• Network pharmacology analysis to map the ligand landscape.
• Molecular descriptors to identify structural similarities.
• Molecular docking to evaluate binding affinities.

Main Results:

• A comprehensive computational pipeline was established.
• Structural similarities between CB2R agonists and M1R modulators were uncovered.
• A shortlist of chemotypes with dual CB2R and M1R regulatory potential was identified.

Conclusions:

• Computational approaches can effectively identify multitarget ligands.
• The identified chemotypes provide a foundation for future experimental validation.
• Dual CB2R-M1R modulation shows potential for treating neurodegenerative disorders.